Ledger. Australian venture funding, tracked

Partner, Cauldron Ferm

Phil Morle

Coverage

Stories naming Phil Morle. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Unnamed stage $158m

The founder of one of Main Sequence’s first investments, medtech Maxwell Plus, on failure, timing, and being ahead of the pack

A retrospective on Maxwell Plus, a machine-vision prostate cancer medtech that folded, with founder Elliot Smith and investor Phil Morle sharing lessons; Harrison.ai's later raise underscores the timing they missed.

Also Startup Daily·Startup Daily·SmartCompany·SmartCompany·Startup Daily·Startup Daily·Forbes Australia·Forbes Australia

3 deals

‘Game changer’: Samsara Eco raises $100 million for infinite recycling of plastics

Australian plastics recycler Samsara Eco secured a Temasek-led Series A+ of $100 million to scale enzyme-based infinite recycling, with Southeast Asian facilities planned, adding to its 2022 Series A.

Also TechCrunch Australia·SmartCompany·@AuManufacturing·Techboard·SmartCompany·@AuManufacturing·@AuManufacturing·@AuManufacturing

3 deals

Eden Brew raises $24.4 million to bring animal-free dairy products to market

Precision fermentation company Eden Brew raised a $24.4 million Series A led by Main Sequence, with Breakthrough Victoria and other backers, to commercialise animal-free dairy and relocate from Sydney to Melbourne.

Also @AuManufacturing·SmartCompany·Startup Daily·Startup Daily·Startup Daily·AgFunderNews·AgFunderNews·Crunchbase News

2 deals

v2food, one of the biggest local names in fake meat, has changed strategy after its founder departed

Plant-based meat maker v2food changed course and is shutting its Wodonga factory after founder-CEO Nick Hazell's departure, with Tim York now chief executive; the story recalls its two Series B raises.

Key hire

Main Sequence announces new Partner, Gabrielle Munzer, to build companies with biology

Australia's Main Sequence fund promotes Gabrielle Munzer to Partner to lead its biotech push; the article also covers her finance background, the firm's company-building model, a UNSW accelerator, and recent diverse hires.

Funding announcement

This week on SUDS, the Startup Daily TV podcast: Tech on women's rights, MCB v AGL, how to raise $100m, what to do with fugly fruit

Preview of the Startup Daily TV podcast covering a bid against AGL's demerger, reproductive-rights tech policy, VC conversations, a fintech fund raise, and interviews with Skedulo, Good & Fugly and One Key Access founders.

Something wrong? Tell us